While statins can reduce LDL levels and ASCVD events, high Lp(a) poses an independent risk that will need attention, too.
As a wave of patent expirations encroaches upon many of the world’s top drugmakers, companies will need to be diligent in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback